Webinar, FAQ Report & Decision Aid | COVID-19 & Neuromuscular Disorders: Ask The Experts

Muscular Dystrophy Canada (MDC) and the Neuromuscular Disease Network for Canada (NMD4C) have received numerous questions about COVID-19 vaccines and how they may uniquely affect people with neuromuscular disorders (NMD).

To address these questions and concerns, MDC & NMD4C assembled a diverse group of neuromuscular, virology, and policy experts to host a webinar with the purpose of answering these topical questions.

From this expert-led webinar, the MDC & NMD4C have developed a frequently asked questions report and decision aid tool as resources to summarize the experts’ answers, and to provide guidance for informed patient decision making.

You can access the Frequently Asked Questions Report, Decision Aid, and webinar recording below!

 

Report: Frequently Asked Questions – COVID-19 & Neuromuscular Disorders

 

Decision Aid: I have a NMD, should I get a vaccine for COVID-19

We are excited to have the following experts address questions about NMDs, COVID-19 and vaccines:

  • Dr. Hans Katzberg, adult neuromuscular specialist and NMD researcher
  • Dr. Hanns Lochmuller, pediatric neuromuscular specialist and NMD researcher
  • Dr. Reshma Amin, respirologist and NMD researcher
  • Dr. Megan Bettle, Director of the COVID-19 Regulatory Response Team at Health Canada / Government of Canada
  • Dr. Allison McGeer, Infectious Disease Specialist and COVID-19 researcher
  • Dr. Anne Pham-Huy, Infectious Disease Specialist and Chair of Immunize Canada
Ask the Experts COVID 19

Read next...

2024 NMD4C Annual Meeting

NMD4C Welcomed Investigators to Annual Meeting in Calgary

Thank you to our investigators who attended the Annual NMD4C Meeting on September 27th in Calgary! Our meeting program consisted of presentations from pillar and task leads which highlighted their groups’ achievements and progress made to date.

LEARNMD logo

NMD4C Launch Educational Platform LEARNMD

LEARNMD is an online educational platform offering talks and sessions on a wide range of neuromuscular topics presented by leading clinical and scientific experts worldwide.

CNDR logo4x3

October 2024 Updates from the Canadian Neuromuscular Disease Registry

The Canadian Neuromuscular Disease Registry (CNDR) is pleased to share updates on several exciting initiatives this fall!

2025 early career awards

2025 Annual NMD4C Early-Career Awards Open for Applications

We are excited to announce the opening of our third annual early-career awards competition!

Canadian neuromuscular fellows attend the WCNMC in Calgary, AB.

NMD4C Provides Opportunity for Neuromuscular Fellows to Build Clinical Network at National Meeting

We are pleased to share that this fall we provided an opportunity for clinical neuromuscular fellows to attend NMD4C’s annual meeting and the Western Canadian Neuromuscular Conference (WCNMC) in Calgary.

newborn screening

NMD4C Investigators Submit Response to CDA Draft Guidance on NBS

A group of NMD4C investigators recently submitted a response to the discussion paper from Canada’s Drug Agency outlining its approach for developing Canadian newborn screening guidance.